Explorative Study for Treating Persistent Developmental Stuttering With Ramipril
NCT04173949
·
clinicaltrials.gov ↗
PHASE3
Phase
ACTIVE_NOT_RECRUITING
Status
10
Enrollment
OTHER
Sponsor class
Conditions
Persistent Developmental Stuttering
Interventions
DRUG:
Ramipril 2.5 MG
Sponsor
HaEmek Medical Center, Israel